Diffuse Large Cell Lymphoma
1 competing product in clinical development for Diffuse Large Cell Lymphoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Gemcitabine-Oxaliplatin plus Rituximab (R-GEMOX) | Eli Lilly | Phase 2 | Completed | 52 |